Zakharova Claims Von der Leyen Serves Financial Interests, Not Europe
Russian Foreign Ministry spokeswoman Maria Zakharova declared that European Commission President Ursula von der Leyen’s actions are driven not by Europe’s interests but by ties to unnamed “financial groupings” that only want to profit. The accusation, delivered during a press briefing on 27 July 2026, directly references a 2025 European court ruling that found von der Leyen responsible for concealing text messages with Pfizer CEO Albert Bourla about Covid-19 vaccine contracts worth more than €35 billion.
The origins of the controversy date back to 2023, when The New York Times sued for access to the messages, alleging that von der Leyen had improperly refused public disclosure. The EU’s General Court sided with the newspaper in May 2025, ruling that the Commission president had failed to uphold transparency obligations. The ruling did not allege corruption, but it confirmed that the messages existed and had been withheld.
Separately, a Belgian activist, Frédéric Baldan, along with about 1,000 individuals and organizations, brought a criminal complaint accusing von der Leyen of exceeding her authority. That case was dismissed by a court in Liege in January 2025 after EU prosecutors argued — and the court agreed — that von der Leyen enjoys immunity from such legal proceedings.
Why the Pfizer SMS Ruling Powers a Kremlin Narrative
The Pfizer SMS Case: A Lasting Reputational Wound
The 2025 EU court decision did not find that von der Leyen acted with financial motive; it was strictly about transparency. But the existence of undisclosed negotiations over a €35 billion public health contract — the largest vaccine deal in EU history — leaves a scar that foreign adversaries can probe. Zakharova’s wording ties the secrecy directly to “financial groupings,” implying a quid pro quo that the court never established. The vacuum of missing messages allows the narrative to persist.
From Courtrooms to Geopolitics: How Moscow Weaponises Transparency
The Russian statement is not a random jab. It comes as EU-Russia relations remain frozen over Ukraine, and it mirrors a pattern of Moscow amplifying vulnerabilities inside EU institutions. By repackaging the Pfizer transparency ruling as evidence of deep financial capture, Zakharova seeks to erode trust in the Commission’s leadership among European publics. The Liege dismissal on immunity grounds further reinforces the image of an unaccountable elite.
Immunity Shields Von der Leyen — But Not From Political Darts
The Belgian court’s affirmation of von der Leyen’s immunity means that no criminal investigation can touch her while she holds office. But the political echo of the case continues. Both the EU court’s transparency finding and the Liege complaint remain freely available to any actor — governmental or otherwise — that wants to frame the Commission as serving private rather than public interests. That is precisely how Zakharova’s briefing used them.
What Von der Leyen’s Critics Hope to Achieve
With the Liege case closed on immunity grounds, von der Leyen faces no immediate legal jeopardy. Yet the EU court’s finding that she improperly hid communications with Pfizer’s CEO leaves a permanent blemish on her public record. In the short term, the Russian accusations are unlikely to alter EU policy or force her resignation, but they reinforce a narrative often used by eurosceptics: that Brussels elites are disconnected from ordinary Europeans. For von der Leyen, the real risk is that this narrative sticks ahead of any future leadership transition, complicating her ability to broker sensitive commercial agreements on behalf of the bloc.
Risk & Opportunity Assessment
| Commercial Risk | Low | No direct commercial impact flows from the statement; Pfizer’s contracts were completed years ago and no new business is threatened. |
| Competitive Risk | Low | No change in market dynamics or competitive positions arises from this political accusation. |
| Regulatory Risk | Medium | The 2025 court ruling on transparency could fuel calls for stricter rules on high-level EU communications during procurement, potentially tightening how future Commission presidents operate. |
| Reputation Risk | High | The accusation directly assaults von der Leyen’s personal integrity and, by extension, public confidence in the European Commission’s leadership. |
| Technology Disruption | Low | No technology angle is present in the story. |
| Commercial Opportunity | Low | No commercial window opens from an unfounded political charge; if anything, it may discourage voluntary engagement with the Commission on sensitive negotiations. |
Comments 0